Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
MARKETS
Equities
United States
North America
Europe
Asia
Middle East
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
More Currencies
Commodities
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
More Commodities
Cryptocurrencies
BITCOIN
ETHEREUM
Trackers & ETF
Rankings and News
Advanced Search
NEWS
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Finance Pro.
Business Leaders
Cryptocurrencies
Cybersecurity
Economic Calendar
Listed companies
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Events
Security Transactions
Financial Calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Real Estate
Utilities
ANALYSIS
All Analysis
Must Read
Daily Briefing
Weekly market update
Stock Trading Strategies
STOCK PICKS
All Stock Picks
Subscribe
PORTFOLIOS
My Portfolio
Virtual Portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
WATCHLISTS
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Yield stocks
Momentum stocks
Trend-Following Stocks
ESG stocks
Undervalued stocks
Quality stocks
Investment Themes
Smart City
US Basketball
Robotics
Hydrogen
Strategic Metals
Sin stocks
RANKINGS
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top ranking ESG
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
SCREENERS
Investment Themes
The Cannabis Industry
Strategic Metals
Gold and Silver
Robotics
Cybersecurity
In Vino Veritas
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
TOOLS
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Tools
Dynamic Chart
Financial Calendar
Economic Calendar
Sector Research
Currency Converter
ProRealTime Trading
OUR SERVICES
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
Homepage
Equities
Germany
Xetra
Eckert & Ziegler Strahlen- und Medizintechnik AG
News
Summary
EUZ
DE0005659700
ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
(EUZ)
Add to my list
Report
Real-time Estimate Tradegate -
05/27 01:32:01 am
42.18
EUR
+0.67%
05/12
Eckert & Ziegler Strahlen- und Medizintechnik AG Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/12
Eckert & Ziegler with Sales Growth in the First Quarter of 2022
EQ
05/12
Eckert & Ziegler Strahlen- und Medizintechnik AG Reaffirms Earnings Guidance for the Year 2022
CI
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
ECKERT & ZIEGLER : DZ Bank reiterates its Sell rating
11/16/2021 | 07:50am EDT
Send by mail :
Name :
First name :
From
*
:
To
*
:
(You can enter multiple email addresses separated by commas)
Message :
*
Required fields
DZ Bank's analyst Sven Kürten maintains his Sell rating on the stock.
© MarketScreener with dpa-AFX Analyser 2021
All news about ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
05/12
Eckert & Ziegler Strahlen- und Medizintechnik AG Reports Earnings Results for the First..
CI
05/12
Eckert & Ziegler with Sales Growth in the First Quarter of 2022
EQ
05/12
Eckert & Ziegler Strahlen- und Medizintechnik AG Reaffirms Earnings Guidance for the Ye..
CI
05/11
Eckert & Ziegler Cooperates with Czech Research Center UJF to Produce Pharmaceutical Al..
EQ
05/11
Eckert & Ziegler Cooperates with Czech Research Center UJF to Produce Pharmaceutical Al..
CI
04/12
ECKERT & ZIEGLER STRAHLEN UND MEDIZI
: Report of the Supervisory Board
PU
04/12
ECKERT & ZIEGLER STRAHLEN UND MEDIZI
: Proposal on the appropriation of net income
PU
04/11
ECKERT & ZIEGLER
: Hauck & Aufhauser remains its Buy rating
MD
04/11
ECKERT & ZIEGLER STRAHLEN UND MEDIZI
: Hauck & Aufhäuser
PU
04/08
ECKERT & ZIEGLER
: Radboud University Medical Center Netherlands to Image First Patient wi..
EQ
More news
Analyst Recommendations on ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
04/11
ECKERT & ZIEGLER
: Hauck & Aufhauser remains its Buy rating
MD
04/04
ECKERT & ZIEGLER
: Hauck & Aufhauser reiterates its Buy rating
MD
2021
ECKERT & ZIEGLER
: DZ Bank reiterates its Sell rating
MD
More recommendations
Financials
EUR
USD
Sales 2022
205 M
220 M
220 M
Net income 2022
30,7 M
32,9 M
32,9 M
Net cash 2022
55,7 M
59,8 M
59,8 M
P/E ratio 2022
28,1x
Yield 2022
1,19%
Capitalization
870 M
933 M
933 M
EV / Sales 2022
3,97x
EV / Sales 2023
3,82x
Nbr of Employees
930
Free-Float
67,1%
More Financials
Chart ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Full-screen chart
Technical analysis trends ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
Short Term
Mid-Term
Long Term
Trends
Bearish
Bearish
Bearish
Technical analysis
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
More Financials
Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
41,90 €
Average target price
152,00 €
Spread / Average Target
263%
Consensus
EPS Revisions
Please enable JavaScript in your browser's settings to use dynamic charts.
More Estimates Revisions
Managers and Directors
Andreas Eckert
Chairman-Executive Board
Wolfgang Maennig
Chairman-Supervisory Board
Helmut Grothe
Vice Chairman-Supervisory Board
Albert Rupprecht
Member-Supervisory Board
Edgar Löffler
Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.
Capi. (M$)
ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
-55.47%
933
JOHNSON & JOHNSON
4.90%
472 652
PFIZER, INC.
-8.57%
301 361
ROCHE HOLDING AG
-12.16%
281 908
ELI LILLY AND COMPANY
13.48%
276 358
ABBVIE INC.
11.20%
268 530
More Results
Master